Oops, you're using an old version of your browser so some of the features on this page may not be displaying properly.

MINIMAL Requirements: Google Chrome 24+Mozilla Firefox 20+Internet Explorer 11Opera 15–18Apple Safari 7SeaMonkey 2.15-2.23

E-Poster Display

1861P - Influence of comprehensive geriatric assessment on therapeutic decision in elderly cancer patients

Date

17 Sep 2020

Session

E-Poster Display

Topics

Supportive Care and Symptom Management

Tumour Site

Presenters

Dalila Miraoui

Citation

Annals of Oncology (2020) 31 (suppl_4): S988-S1017. 10.1016/annonc/annonc291

Authors

D. Miraoui1, S. Ghomari2, F. Bereksi Reguig1, F. Moulesshoul1, N. Maaref3

Author affiliations

  • 1 Medicine, Université Djillali Liabés, 22000 - Sidi Bel Abbès/DZ
  • 2 Medicine, Laboratoire Toxicomed, Universite Abou Bakr Belkaid, 13000 - tlemcen/DZ
  • 3 Medicine, Université Djillali Liabés, 22000 - Sidi Bel Abbès/FR

Resources

Login to get immediate access to this content.

If you do not have an ESMO account, please create one for free.

Abstract 1861P

Background

The elderly population heterogeneity in terms of comorbidities and functional status may explain the difficulty in establishing management recommendations. The Comprehensive Geriatric Assessment (CGA) is a multidimensional assessment of general health status. The CGA is a tool used to discriminate between different groups of patients with different frailty levels. Our objective was to assess the CGA influence in therapeutic decisions and to identify the CGA parameters associated with therapeutic modifications.

Methods

AA prospective study was conducted in elderly cancer patients. A comprehensive geriatric assessment has been performed. Treatment decision was taken initially by the staff of oncologists according to the guidelines without geriatric assessment and secondly according to the results of CGA. The decision modification was either to intensify the treatment or to reduce it. An univariate and multivariate analysis were used to identify factors associated with changes in the cancer treatment.

Results

200 patients were included. Mean age was 74.3 ± 6.2 years [65-93]. Colorectal cancer (33.5%) and lung cancer (31.5%) were the most common localization. 110 patients had ≥ 1 comorbidity and 142 were taking <3 medications. 45.5% were in good performance status (PS 1). G8 was <14 in 45.5%, 52 % were dependant for 1 to 3 activities of daily living (ADL). 31.5 % were dependant for 3 to 4 activities of instrumental daily living (IADL). Half of patients had impaired mobility; 28.5 % presented medium cognitive impairment. 47.5% presented a poor nutritional status. Patients were fit (39%), vulnerables (45.5%) and frail (15.5%).After CGA, the chemotherapy treatment plan was modified for 49 patients, intensity treatment was increase in 31 patients and decrease in 18 patients.By univariate analysis, treatment changes were associated with age (p=0.007) and dependency for one or more activities of daily living ADL (p=0.02). Multivariate analysis showed that only the age ≥ 75 years had a statistically significant p=0.04 (OR: 0.49 IC [0.25-0.98]).

Conclusions

The geriatric assessment has an impact on the therapeutic decision of old patients. Changes in treatment decisions were correlated with age and ADL dependence.

Clinical trial identification

Editorial acknowledgement

Legal entity responsible for the study

Miraoui Dalila.

Funding

Has not received any funding.

Disclosure

All authors have declared no conflicts of interest.

This site uses cookies. Some of these cookies are essential, while others help us improve your experience by providing insights into how the site is being used.

For more detailed information on the cookies we use, please check our Privacy Policy.

Customise settings
  • Necessary cookies enable core functionality. The website cannot function properly without these cookies, and you can only disable them by changing your browser preferences.